Results 11 to 20 of about 352,837 (117)

The European Falsified Medicines Directive in Poland: background, implementation and potential recommendations for pharmacists [PDF]

open access: yesEuropean Journal of Hospital Pharmacy, 2018
By February 2019, the Polish pharmaceutical industry, community and hospital pharmacies, wholesalers and parallel traders must all comply with the EU-wide Falsified Medicines Directive (FMD) legislation (2011/62/EU), to ensure that no medicinal product is dispensed to a patient without proper tracking and authentication.
Bernard Naughton   +2 more
exaly   +8 more sources

EU Falsified Medicines Directive mandatory requirements for secondary care: A concise review [PDF]

open access: yesJournal of Generic Medicines, 2015
Since the publication of the Falsified Medicines Directive in 2011 and the subsequent delegated regulation in February 2016, there has been much discussion surrounding the level of Falsified Medicines Directive compliance required by secondary care institutions.
Bernard Naughton
exaly   +6 more sources

Falsified Medicines—Bridging the Gap between Business and Public Health [PDF]

open access: yesPharmacy (Basel, Switzerland), 2016
The pharmaceutical industry is one of the most regulated industries in the world. While legislation is necessary to protect patients, too much legislation is said to hamper innovation and increase medicine prices.
Rasmus Borup
exaly   +4 more sources

Awareness of the implementation of the Falsified Medicines Directive among pharmaceutical companies' professionals in the European Economic Area. [PDF]

open access: yesPharm Pract (Granada), 2017
The Falsified Medicines Directive (FMD) is a response of the European Union to the increasing number of falsified medicines present in the legal supply chain within the Member States of the community. Effective implementation of the new regulations will depend on the effective cooperation of all parties involved in the distribution of medicinal ...
WŁodarczak U   +6 more
europepmc   +7 more sources

2SPD-029 Impact of the implementation of the falsified medicines directive on a healthcare institution [PDF]

open access: yesEuropean Journal of Hospital Pharmacy. Science and Practice, 2018
Background The Directive 2011/62/EU (Falsified medicines directive, FMD) provides for measures to prevent the entry into the legal supply chain of falsified medicinal products and has been supplemented by the commission delegated regulation (EU) 2016/161. From February 2019 onwards prescription medicines are required to bear individual safety features
M Hug
exaly   +4 more sources

Sounding out falsified medicines from genuine medicines using Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS) [PDF]

open access: yesScientific Reports, 2021
The trade in falsified medicine has increased significantly and it is estimated that global falsified sales have reached $100 billion in 2020. The EU Falsified Medicines Directive states that falsified medicines do not only reach patients through illegal
Anas Alfarsi   +9 more
doaj   +2 more sources

The Falsified Medicines Directive: How to secure your supply chain. [PDF]

open access: yesJ Generic Med, 2014
With new EU-wide legislation being introduced to protect patients from falsified medicines, how can the existing supply chain adapt and thrive in this new, safer environment? Falsified medicines, and supply chain security in general, are a global issue gaining great political and consumer attention.1 Although no formal study has been carried out on ...
Smith G, Smith JA, Brindley DA.
europepmc   +4 more sources

EU: Falsified Medicines Directive 'Delegated Act' accepted by European Parliament. [PDF]

open access: yesEur J Hosp Pharm, 2016
A ‘Delegated Act’ of the European Commission setting out requirements hospital pharmacies must fulfil in respect to ‘check out’ verification of all medicines they receive, has been accepted by the European Parliament. The Act is now formal European Union law and must be implemented by a deadline of 9 February 2019.
Price R.
europepmc   +4 more sources

THE IMPACT OF THE EUROPEAN DIRECTIVE AGAINST FALSIFIED MEDICINES ON THE PHARMACEUTICAL WHOLESALERS IN BULGARIA [PDF]

open access: yesJournal of IMAB, 2021
In the last few decades, the problem with falsified medicine became a global threat that accounts for millions of human lives and billions of financial loses for the national health authorities and pharmaceutical industry.
Krasimira Valcheva
doaj   +2 more sources

Models of implementation of the falsified medicines directive in different dispensing scenarios

open access: yesActa Poloniae Pharmaceutica - Drug Research, 2021
To minimize the burden and maximize the benefits of the Falsified Medicines Directive implementation in the setting of hospital pharmacy, an assessment of European hospital pharmacies aiming to map workflows of medicines dispensation was used. Different dispensation models were analyzed, aiming for the best implementation of the directive requirements.
Merks, Piotr   +10 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy